These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1325952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.
    Busso N, Péclat V, So A, Sappino AP.
    Ann Rheum Dis; 1997 Sep; 56(9):550-7. PubMed ID: 9370880
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
    Lund LR.
    FEBS Lett; 1996 Apr 01; 383(3):139-44. PubMed ID: 8925884
    [Abstract] [Full Text] [Related]

  • 7. Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines.
    Lyon PB, See WA, Xu Y, Cohen MB.
    Prostate; 1995 Oct 01; 27(4):179-86. PubMed ID: 7479384
    [Abstract] [Full Text] [Related]

  • 8. Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients.
    Kotzsch M, Magdolen V, Greither T, Kappler M, Bache M, Lautenschläger C, Füssel S, Eckert AW, Luther T, Baretton G, Würl P, Taubert H.
    BMC Cancer; 2011 Jun 25; 11():273. PubMed ID: 21702998
    [Abstract] [Full Text] [Related]

  • 9. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression.
    Liu K, Liu YX, Hu ZY, Zou RY, Chen YJ, Mu XM, Ny T.
    Mol Cell Endocrinol; 1997 Oct 20; 133(2):109-16. PubMed ID: 9406856
    [Abstract] [Full Text] [Related]

  • 10. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ, Krikun G, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1996 Jan 20; 81(1):107-12. PubMed ID: 8550736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney.
    Xu Y, Hagege J, Mougenot B, Sraer JD, Rønne E, Rondeau E.
    Kidney Int; 1996 Dec 20; 50(6):2011-9. PubMed ID: 8943484
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V, Antinheimo JP, Jääskeläinen J, Böhling T, Carpén O, Vaheri A.
    Acta Neurochir (Wien); 2004 Feb 20; 146(2):111-8. PubMed ID: 14963743
    [Abstract] [Full Text] [Related]

  • 19. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.
    Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD.
    Placenta; 1998 Feb 20; 19(2-3):171-80. PubMed ID: 9548184
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue.
    Dow MP, Bakke LJ, Cassar CA, Peters MW, Pursley JR, Smith GW.
    Biol Reprod; 2002 May 20; 66(5):1413-21. PubMed ID: 11967205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.